ANGIO Mentor was the most highly validated and effective vascular simulator and the only simulator to achieve an LoE of 5/5¶
Claim · All claims
Evidence · 1 study · reviewr3·q2
Currency · newest study 2022 · not yet checked against its sources · not reviewed by a person · overdue for a recheck since 2025: tool and model accuracy changes quickly
Subclaims¶
Reading the evidence codes
q is the design tier, i the impact, n the sample, and the kind with its r
the rigour judged within that kind: what each code means.
This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.
q2 i? ANGIO Mentor, a high-fidelity VR endovascular simulator, was validated by twelve studies for angioplasty and stenting and five for EVAR, and achieved LoE 5/5 because proficiency was retained up to 3 months alongside improved patient outcomes and operative performance. → Haiser Alexander 2022
Evidence¶
Haiser Alexander 2022¶
Haiser Alexander, Aydin Abdullatif, Kunduzi Basir, Ahmed Kamran, Dasgupta Prokar. (2022). A Systematic Review of Simulation-Based Training in Vascular Surgery. The Journal of Surgical Research. https://doi.org/10.1016/j.jss.2022.05.009
q2 · i? · review · r3
Review synthesis of validation studies for ANGIO Mentor in angioplasty and stenting. The review reports the simulator differentiated performance between 32 surgical trainees, 20 vascular surgeons and 29 medical students, and that "proficiency levels were retained up to 3 mo" in the Maertens randomized controlled trial.
"Maertens et al. was awarded an LoE of 5/5 as proficiency levels were retained up to 3 mo, alongside an improvement in patient outcomes and better operative performance."
Discussion¶
Related Claims¶
- A systematic review identified 76 eligible articles validating 34 vascular surgery simulators and training courses for open and endovascular procedures — a broader claim this one bears on
- VIST endovascular simulator training transferred to real-world performance, with improved technical skill metrics on real patients (LoE 3/5) — related
- Only seven studies of vascular surgery simulation achieved a level of effectiveness greater than 3/5, with the majority scoring LoE 1-2/5 — related
- Nontechnical-skills simulation of ruptured AAA with the Resusci Anne Simulator directly improved patient outcomes, reducing door-to-occlusion time, door-to-needle time, and 30-day mortality (LoE 4/5) — related
Page metadata
| Field | Value |
|---|---|
status |
review |
generated |
by process:wiki-ingest on 2026-10-31 |
trust |
unverified — no one has confirmed this page's content |
Frontmatter is the page's machine-readable record — see the Schema & Guide.